People with type 2 diabetes exhibit a huge variety of characteristics, making understanding the condition in phenotypic terms a complex business. This module highlights just how important such efforts are to the pursuit of patient-centred care and precision medicine.
By the end of this module, you will be able to:
✓ Explain the potential treatment implications of phenotyping for type 2 diabetes and the importance of patient-centred care in shared therapeutic decision making
✓ Explain the role of genotyping for patients with type 2 diabetes and the treatment options for people diagnosed with monogenic subtypes of diabetes
✓ Examine the HbA1c and ABCD of glycaemia management in type 2 diabetes and the role of biomarkers in the management of type 2 diabetes
This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.